SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Repurposing Drugs in Oncology: Next Steps · Study

ArticleShelves

ArticleRepurposing Drugs in Oncology: Next Steps

Ciska Verbaanderd2017

Article2017

Repurposing Drugs in Oncology: Next Steps

Ciska Verbaanderd · Lydie Meheus · Isabelle Huys · Pan Pantziarka

85 citations·0/0 files stored·Trends in cancer

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Computational Drug Discovery Methods Historical Medical Research and Treatments

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 85 citations exist upstream.

References

2015Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries 2016ecancermedicalscience

Cited by

2020On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2016Overcoming Challenges Facing Advanced Therapies in the EU Marketarticle · 1 shared reference 2023Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapyarticle · 1 shared reference 2018Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Grouparticle · 1 shared reference 2020A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countriesreview · 1 shared reference 2020Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysisreview · 1 shared reference 2017Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)article · 1 shared reference

Details

Year2017

Typearticle

Published2017-07-13

VenueTrends in cancer

ISSN-L2405-8025

Languageen

Citations85

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.trecan.2017.06.007

openalex_workW2735892091

Links

Imported from OpenAlex (CC0) — nothing here is generated.